Grady, Deborah <br/><br/>
Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk.  [electronic resource] 

 -  Journal of the National Cancer Institute  Jun 2008 
 - 854-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2105 
<br/><br/><label>Standard No.: </label>10.1093/jnci/djn153  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Bone Density Conservation Agents--therapeutic use<br/>Breast Neoplasms--epidemiology<br/>Coronary Disease--etiology<br/>Female<br/>Fractures, Bone--epidemiology<br/>Humans<br/>Incidence<br/>Lymphatic Metastasis<br/>Middle Aged<br/>Neoplasm Invasiveness<br/>Neoplasm Staging<br/>Odds Ratio<br/>Osteoporosis, Postmenopausal--complications<br/>Proportional Hazards Models<br/>Raloxifene Hydrochloride--therapeutic use<br/>Risk Assessment<br/>Risk Factors<br/>Selective Estrogen Receptor Modulators--therapeutic use<br/>Spine